Literature DB >> 25619382

Increased risk of severe vaso-occlusive episodes after initial acute chest syndrome in children with sickle cell anemia less than 4 years old: Sleep and asthma cohort.

Leah D Vance1, Mark Rodeghier, Robyn T Cohen, Carol L Rosen, Fenella J Kirkham, Robert C Strunk, Michael R DeBaun.   

Abstract

Previous studies have shown that the highest incidence of acute chest syndrome (ACS) in sickle cell disease occurs in children <4 years old, and a history of ACS at this age is a risk factor for future ACS episodes. However, the interval associated with the highest risk of subsequent ACS or severe pain is not known. Through this mixed retrospective-prospective observational study, the Sleep and Asthma Cohort, we sought to determine the interval after an initial ACS episode during which the majority of children <4 years old are rehospitalized for ACS or severe pain. The cumulative prevalence of rehospitalization for ACS or severe pain within 6 months, 1 years, and 2 years was calculated for children with an initial ACS episode <4 years old and compared to children with an initial ACS episode ≥4 years old. A total of 44.8% and 55.2% of participants had an initial ACS episode <4 years and ≥4 years old (Range: 4-17.7 years), respectively. At 1 year following the initial ACS episode, children <4 years old had a significantly higher cumulative prevalence of rehospitalizations for ACS or pain as compared to children ≥4 years of age, 62.5 and 39.1%, respectively (P = 0.009). After initial ACS episodes, the majority of children <4 years old will be rehospitalized for ACS or severe pain within one year, suggesting the need for a therapeutic intervention for this high-risk group.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 25619382      PMCID: PMC4409481          DOI: 10.1002/ajh.23959

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  29 in total

Review 1.  The acute chest syndrome of sickle cell disease.

Authors:  C T Quinn; G R Buchanan
Journal:  J Pediatr       Date:  1999-10       Impact factor: 4.406

Review 2.  Virus-induced airway dysfunction: pathogenesis and biomechanisms.

Authors:  Azzeddine Dakhama; Young Mok Lee; Erwin W Gelfand
Journal:  Pediatr Infect Dis J       Date:  2005-11       Impact factor: 2.129

3.  Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea.

Authors:  M H Steinberg; Z H Lu; F B Barton; M L Terrin; S Charache; G J Dover
Journal:  Blood       Date:  1997-02-01       Impact factor: 22.113

4.  Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses.

Authors:  G P Rakes; E Arruda; J M Ingram; G E Hoover; J C Zambrano; F G Hayden; T A Platts-Mills; P W Heymann
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

5.  Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease.

Authors:  E P Vichinsky; L A Styles; L H Colangelo; E C Wright; O Castro; B Nickerson
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

6.  Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia.

Authors:  Jessica H Boyd; Eric A Macklin; Robert C Strunk; Michael R DeBaun
Journal:  Blood       Date:  2006-05-11       Impact factor: 22.113

7.  Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.

Authors:  A Koren; D Segal-Kupershmit; L Zalman; C Levin; M Abu Hana; H Palmor; A Luder; D Attias
Journal:  Pediatr Hematol Oncol       Date:  1999 May-Jun       Impact factor: 1.969

8.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

9.  The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease.

Authors:  O Castro; D J Brambilla; B Thorington; C A Reindorf; R B Scott; P Gillette; J C Vera; P S Levy
Journal:  Blood       Date:  1994-07-15       Impact factor: 22.113

10.  Duration of postviral airway hyperresponsiveness in children with asthma: effect of atopy.

Authors:  Paraskevi Xepapadaki; Nikolaos G Papadopoulos; Apostolos Bossios; Emmanuel Manoussakis; Theodoros Manousakas; Photini Saxoni-Papageorgiou
Journal:  J Allergy Clin Immunol       Date:  2005-08       Impact factor: 10.793

View more
  6 in total

Review 1.  The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia.

Authors:  Michael R DeBaun; Robert C Strunk
Journal:  Lancet       Date:  2016-06-18       Impact factor: 79.321

2.  Community Health Workers as Support for Sickle Cell Care.

Authors:  Lewis L Hsu; Nancy S Green; E Donnell Ivy; Cindy E Neunert; Arlene Smaldone; Shirley Johnson; Sheila Castillo; Amparo Castillo; Trevor Thompson; Kisha Hampton; John J Strouse; Rosalyn Stewart; TaLana Hughes; Sonja Banks; Kim Smith-Whitley; Allison King; Mary Brown; Kwaku Ohene-Frempong; Wally R Smith; Molly Martin
Journal:  Am J Prev Med       Date:  2016-07       Impact factor: 5.043

3.  Inhaled corticosteroid use to prevent severe vaso-occlusive episode recurrence in children between 1 and 4 years of age with sickle cell disease: a multicenter feasibility trial.

Authors:  Leah Vance Utset; Zalaya Ivy; Shaina M Willen; Mark Rodeghier; Amanda Watt; Leann Schilling; Chantel L Jenkins; Stefanie Pepper; Barbara Speller-Brown; Deepika S Darbari; Suvankar Majumdar; Olufolake Adisa; Michael R DeBaun
Journal:  Am J Hematol       Date:  2018-02-05       Impact factor: 10.047

Review 4.  Acute Chest Syndrome in Children with Sickle Cell Disease.

Authors:  Shilpa Jain; Nitya Bakshi; Lakshmanan Krishnamurti
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2017-12-01       Impact factor: 1.349

5.  Cardiorespiratory pathogenesis of sickle cell disease in a mouse model.

Authors:  Jun Ren; Xiuqing Ding; Marie Trudel; John J Greer; Joanna E MacLean
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

6.  Improved Guideline Adherence With Integrated Sickle Cell Disease and Asthma Care.

Authors:  Brandi L McClain; Zalaya K Ivy; Valencia Bryant; Mark Rodeghier; Michael R DeBaun
Journal:  Am J Prev Med       Date:  2016-07       Impact factor: 5.043

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.